通过准JAK2/STAT3/c-Myc轴,CMSP抑制了口腔状细胞癌的进展
Yueting Lu1, Manman Yao1, Dixian Wang1
1Department of Stomatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Frontiers in oncology
|December 5, 2025
概括
p-hydroxycinnamaldehyde (CMSP) 显示了对口腔状细胞癌 (OSCC) 的抗瘤作用. 通过向JAK2/STAT3/c-Myc通路,CMSP抑制了OSCC细胞的生长和迁移.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 口腔状细胞癌 (OSCC) 是一种具有攻击性的头癌,治疗选择有限.
- p-hydroxycinnamaldehyde (CMSP) 是一种来自Momordica cochinchinensis的生物活性化合物,具有潜在的抗癌特性.
研究的目的:
- 为了研究p-hydroxycinnamaldehyde (CMSP) 在口腔状细胞癌 (OSCC) 中的抗瘤潜力.
- 阐明CMSP抗OSCC作用背后的分子机制.
主要方法:
- 在体外研究中使用OSCC细胞系 (CAL27,SCC15) 和体内异种移植小鼠模型.
- 检测细胞增殖,迁移,入侵,细胞循环和细胞亡.
- 转录组测序,KEGG/GO丰富,西式抹杀,生物信息学和分子对接.
主要成果:
- CMSP显著抑制了OSCC细胞的增殖,迁移和入侵.
- 在OSCC细胞中,CMSP诱导了S相停止并促进了细胞亡.
- CMSP抑制了JAK2 / STAT3信号通路并降低了c-Myc表达的调节,从而减少了体内瘤的生长.
结论:
- CMSP表现出显著的反OSCC活动,部分通过JAK2/STAT3/c-Myc信号轴.
- CMSP显示出作为OSCC管理的辅助治疗剂的潜力.
相关概念视频
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K

